ACG, a global leader in integrated solutions for pharmaceutical and nutraceutical industries, has announced the commencement of operations at its state-of-the-art capsule manufacturing facility in Thailand. The new plant represents a significant milestone in ACG’s commitment to expanding its global footprint and meeting the growing demand for high-quality capsule products in Asia and beyond.
Strategically located to serve the burgeoning pharmaceutical and nutraceutical markets in Southeast Asia, the facility is among the largest of its kind in the region. It boasts advanced technology, sustainable manufacturing practices, and compliance with stringent global regulatory standards, underscoring ACG’s dedication to innovation and excellence.
The fully operational plant is equipped with advanced production lines capable of manufacturing a wide range of hard gelatin and HPMC capsules. These capsules cater to diverse pharmaceutical and nutraceutical formulations, offering versatility and reliability for customers.
The investment in this Thailand facility aligns with ACG’s strategic vision to strengthen its manufacturing capabilities and support the global healthcare industry’s evolving needs. The company remains committed to enhancing its product portfolio and delivering value to its partners.
With this expansion, ACG is set to play a pivotal role in supporting the pharmaceutical and nutraceutical sectors in the region, enabling companies to innovate and scale with confidence.
